What happens if you stop taking Wegovy for two weeks?

Does two weeks off Wegovy actually change anything in your body?

Semaglutide has a half-life of approximately seven days. That means that after your first missed weekly injection, the circulating level of the medicine is already roughly half what it was at its peak. After a second missed injection (the two-week point) it has fallen to around a quarter of its working concentration. You are not simply pressing pause; the drug's effect on your GLP-1 receptors is actively winding down throughout that window.

The practical consequence most people notice first is hunger. The GLP-1 pathway is responsible for slowing gastric emptying and reinforcing satiety signals. As semaglutide clears your system, gastric emptying speeds back up and those fullness cues weaken. Clinical trial follow-up data (including the STEP 1 extension, published in the New England Journal of Medicine) showed that participants who stopped semaglutide regained a substantial proportion of lost weight over the subsequent year. Two weeks is a far shorter gap than that, but reading about what happens when you stop taking Wegovy makes clear that the underlying biology is the same: the medicine is not changing your set point permanently, so appetite tends to reassert itself quickly once levels drop.

For some people this is barely noticeable, particularly those who have been on a stable maintenance dose for a long time. For others, especially those who stopped mid-titration or who are sensitive to appetite fluctuation, understanding what happens to your body when you stop taking Wegovy can help you recognise why the shift within a fortnight can feel significant. Worth knowing before you decide whether a break is worth it.

Will you need to retitrate if you restart after a two-week gap?

This is probably the most practically important question. The NHS patient information for semaglutide and the medicine's Summary of Product Characteristics both address missed doses: if more than 14 days have passed since a missed injection, treatment should be restarted at the 0.25mg starting dose and titrated again from the beginning. If fewer than 14 days have passed, you take the missed dose as soon as you remember, provided your next scheduled injection is not within two days.

Two weeks lands right at that clinical threshold. Whether the gap is 13 days or 15 makes a real difference to how you resume, and that boundary is drawn for good reason. Jumping back to a higher dose after a break increases the risk of the gastrointestinal side effects (nausea, vomiting, diarrhoea) that the titration schedule exists to minimise. A prescriber will consider how long you were at a given dose before stopping, your tolerance history and your current circumstances before advising you. That conversation matters more than self-managing based on where you were.

At nume, every repeat order goes through a fresh clinical review before anything is dispensed. A prescriber reads your updated answers, not a rule engine. If a gap has occurred, that review is where the re-titration question gets answered for your specific situation.

What about the longer picture, does stopping briefly undermine overall progress?

Short gaps are unlikely to erase months of progress on their own, but they are not neutral either. If you are curious about what happens when you stop taking Wegovy for weight loss, the research is clear: without the drug, the brain's appetite regulation tends to revert toward its pre-treatment state. Two weeks is not long enough for full reversal, but it is long enough for cravings to increase, portion satisfaction to dip and, for some people, old eating patterns to start re-establishing themselves.

The clinical guidance from NHS England on weight management injections emphasises that these treatments work best alongside consistent behavioural and dietary changes. A planned break, managed with your prescriber, is very different from an unplanned gap caused by supply issues or forgetting. If your reason for pausing is side effects, cost or practical logistics, all three are worth raising with a clinician rather than stopping unilaterally, there may be options you have not considered. A look at the cost context for Wegovy in the UK is sometimes a useful starting point for the financial piece.

If the gap was unavoidable and you are now wondering how to get back on track, the most useful next step is a prescriber conversation rather than a forum search. The detail of your situation (how long you were on treatment, what dose you reached, why the break happened) shapes the right answer in ways a general article cannot.

Are there situations where a break is clinically planned?

Yes. There are circumstances where a prescriber will recommend a deliberate pause: upcoming surgery is one of the clearest examples. NHS England advises telling your anaesthetist and surgical team that you take a GLP-1 medicine, and in some cases the clinical team will request a break before a procedure because of the medicine's effect on gastric emptying and aspiration risk. This is a planned, supervised pause with a clear restart plan, the opposite of stopping because you ran out of pens.

Pregnancy, a confirmed pregnancy, or a decision to start trying to conceive is another situation where stopping is recommended rather than optional. Semaglutide is not recommended in pregnancy or breastfeeding, and knowing what happens if you stop Wegovy in these circumstances is important, because the medicine should be discontinued with appropriate planning and prescriber oversight. If any of these situations apply to you, the right starting point is a direct conversation via our clinical support team rather than guessing at the right approach.

For questions that fall somewhere in between (a holiday, an illness that caused vomiting and you are unsure whether the dose absorbed, a stockout) the FAQs cover some common scenarios, but a clinical review is always the definitive answer. You can also read more about what happens after you stop taking Wegovy if you want a broader overview before speaking to your prescriber.